SCHEMBL15436306

SCHEMBL15436306

Cc1cn(I)c(C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23344394 0.74
SCHEMBL486467 0.69
Water SCHEMBL7594635 0.67
Iodide SCHEMBL3791317 0.67
SCHEMBL22890849 0.67
SCHEMBL8737200 0.63 ALDH1A1 (0.32)
SCHEMBL23204987 0.60 WDR5 (0.32)
SCHEMBL19928170 0.60 ALDH1A1 (0.30)
SCHEMBL24663000 0.60 KDM4E (0.40)
SCHEMBL18630421 0.60 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106061963-B Heterocyclic modulators of lipid synthesis and combinations thereof 3-V生物科学股份有限公司 2019-10-22 CN disclosed
US-9926308-B2 N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-03-27 US disclosed
CN-106061963-A Heterocyclic modulators of lipid synthesis and combinations thereof 3-V生物科学股份有限公司 2016-10-26 CN disclosed
CN-104507928-B Heterocyclic modulators of lipid synthesis 3-V生物科学股份有限公司 2016-09-28 CN disclosed
EP-2687513-A1 Drugs for inhibiting aggregation of proteins invoved in diseases linked to protein aggregation and/or neurodegenerative diseases Ludwig-Maximilians-Universität München (DE) 2014-01-22 EP disclosed